Medicare Enrolled

Dr. Garrett Camp, FNP-C

Dermatology · Texarkana, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
2011 MOORES LN, Texarkana, TX 75503
9037922777
In practice since 2018 (7 years)
NPI: 1649756198 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Camp from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Camp? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Camp

Dr. Garrett Camp is a dermatology specialist in Texarkana, TX, with 7 years of NPI registration. Based on federal Medicare data, Dr. Camp performed 414 Medicare services across 244 unique beneficiaries.

Between the years covered by Open Payments, Dr. Camp received a total of $9,332 from 26 pharmaceutical and/or device companies across 483 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Camp is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 7 years in practice ▲ 414 Medicare services $9,332 industry payments

Medicare Practice Summary

Medicare Utilization ↗
414
Medicare services
Bottom 9% in TX for dermatology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
244
Unique beneficiaries
$33
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~59 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Destruction of precancerous skin growths, 2-14 188 $4 $7
Office visit, established patient (20-29 min) 86 $56 $89
Destruction of precancerous skin growth, 1 50 $34 $67
New patient office visit (30-44 min) 50 $67 $111
Office visit, established patient (30-39 min) 29 $83 $125
Skin biopsy, tangential 11 $59 $101
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$9,332
Total received (2021-2024)
Avg $2,333/year across 4 years
Top 28% in TX for dermatology
26
Companies
483
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,115 (97.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$216 (2.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,890
2023
$2,623
2022
$2,096
2021
$1,722

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$1,716
Janssen Biotech, Inc.
$1,599
Lilly USA, LLC
$875
Regeneron Healthcare Solutions, Inc.
$647
Novartis Pharmaceuticals Corporation
$625
NOVARTIS PHARMACEUTICALS CORPORATION
$570
UCB, Inc.
$392
SUN PHARMACEUTICAL INDUSTRIES INC.
$361
E.R. Squibb & Sons, L.L.C.
$347
AbbVie Inc.
$326
Arcutis Biotherapeutics, Inc.
$286
Almirall LLC
$269
Dermavant Sciences, Inc.
$254
Amgen Inc.
$207
Sun Pharmaceutical Industries Inc.
$178
Incyte Corporation
$164
GENZYME CORPORATION
$110
PFIZER INC.
$108
Ortho Dermatologics, a division of Bausch Health US, LLC
$78
VYNE Pharmaceuticals Inc.
$45
Journey Medical Corporation
$39
Galderma Laboratories, L.P.
$34
LEO Pharma Inc.
$31
DERMIRA, INC.
$27
Kyowa Kirin, Inc.
$24
SANOFI-AVENTIS U.S. LLC
$20
Top 3 companies account for 44.9% of total payments
Associated products mentioned in payments ›
ADBRY · AKLIEF · AMZEEQ · ARAZLO · Bimzelx · COSENTYX · Cimzia · DUOBRII · DUPIXENT · EUCRISA · HUMIRA · ILUMYA · Ilumya · JUBLIA · Klisyri · OLUMIANT · OPZELURA · Otezla · Poteligeo · QBREXZA · REMICADE · RINVOQ · SILIQ · SKYRIZI · Seysara · Sotyktu · TALTZ · TREMFYA · VTAMA · Winlevi · ZILXI · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $2,254 per 100 Medicare services performed
Looking for a dermatology specialist in Texarkana?
Compare dermatologists in the Texarkana area by procedure volume, costs, and industry payment transparency.
Browse dermatologists nearby

Geographic Context

Dermatologists within 10 mi
3
Per 100K population
3.2
County median income
$59,295
Nearest hospital
CHRISTUS ST MICHAEL HEALTH SYSTEM
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Camp is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Camp experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Camp performed 188 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Camp receive payments from pharmaceutical companies?
Yes. Dr. Camp received a total of $9,332 from 26 companies across 483 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Camp's costs compare to other dermatologists in Texarkana?
Dr. Camp's average Medicare payment per service is $33. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Camp) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →